Glenmark Pharmaceuticals Limited (GLENMARK.BO)
INR 1541.0
(1.1%)
INR 1541.0
(1.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 118.13 Billion INR | -7.17% |
| 2022 | 127.25 Billion INR | 4.53% |
| 2021 | 121.74 Billion INR | 12.66% |
| 2020 | 108.06 Billion INR | 3.93% |
| 2019 | 103.97 Billion INR | 7.13% |
| 2018 | 97.05 Billion INR | 8.51% |
| 2017 | 89.43 Billion INR | 0.9% |
| 2016 | 88.63 Billion INR | 20.27% |
| 2015 | 73.7 Billion INR | 13.01% |
| 2014 | 65.21 Billion INR | 10.09% |
| 2013 | 59.23 Billion INR | 19.21% |
| 2012 | 49.69 Billion INR | 23.59% |
| 2011 | 40.2 Billion INR | 36.34% |
| 2010 | 29.49 Billion INR | 17.93% |
| 2009 | 25 Billion INR | 18.18% |
| 2008 | 21.16 Billion INR | 5.32% |
| 2007 | 20.09 Billion INR | 60.54% |
| 2006 | 12.51 Billion INR | 65.2% |
| 2005 | 7.57 Billion INR | 23.78% |
| 2004 | 6.12 Billion INR | 60.79% |
| 2003 | 3.8 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 32.44 Billion INR | 5.92% |
| 2023 FY | 118.13 Billion INR | -7.17% |
| 2023 Q4 | 30.62 Billion INR | 24.5% |
| 2023 Q1 | 33.36 Billion INR | 1.08% |
| 2023 Q2 | 31.6 Billion INR | -5.26% |
| 2023 Q3 | 24.6 Billion INR | -22.16% |
| 2022 Q4 | 33 Billion INR | -2.7% |
| 2022 Q3 | 33.92 Billion INR | 13.73% |
| 2022 Q2 | 29.82 Billion INR | 9.65% |
| 2022 FY | 127.25 Billion INR | 4.53% |
| 2022 Q1 | 27.2 Billion INR | -8.14% |
| 2021 Q3 | 31.41 Billion INR | 0.51% |
| 2021 Q2 | 31.25 Billion INR | 6.09% |
| 2021 Q1 | 29.46 Billion INR | 4.11% |
| 2021 Q4 | 29.61 Billion INR | -5.74% |
| 2021 FY | 121.74 Billion INR | 12.66% |
| 2020 Q1 | 23.09 Billion INR | -14.83% |
| 2020 FY | 108.06 Billion INR | 3.93% |
| 2020 Q2 | 29.08 Billion INR | 25.93% |
| 2020 Q3 | 27.58 Billion INR | -5.14% |
| 2020 Q4 | 28.29 Billion INR | 2.58% |
| 2019 Q3 | 26.38 Billion INR | -4.53% |
| 2019 Q4 | 27.11 Billion INR | 2.75% |
| 2019 FY | 103.97 Billion INR | 7.13% |
| 2019 Q1 | 22.83 Billion INR | -9.6% |
| 2019 Q2 | 27.63 Billion INR | 21.02% |
| 2018 FY | 97.05 Billion INR | 8.51% |
| 2018 Q1 | 21.29 Billion INR | -5.27% |
| 2018 Q3 | 25.09 Billion INR | -1.18% |
| 2018 Q2 | 25.39 Billion INR | 19.28% |
| 2018 Q4 | 25.26 Billion INR | 0.65% |
| 2017 Q3 | 21.71 Billion INR | -2.34% |
| 2017 FY | 89.43 Billion INR | 0.9% |
| 2017 Q4 | 22.47 Billion INR | 3.52% |
| 2017 Q2 | 22.23 Billion INR | -4.55% |
| 2017 Q1 | 23.29 Billion INR | -3.92% |
| 2016 Q2 | 21.73 Billion INR | 13.81% |
| 2016 Q3 | 24.62 Billion INR | 13.33% |
| 2016 FY | 88.63 Billion INR | 20.27% |
| 2016 Q4 | 24.24 Billion INR | -1.56% |
| 2016 Q1 | 19.09 Billion INR | -13.18% |
| 2015 FY | 73.7 Billion INR | 13.01% |
| 2015 Q2 | 18.78 Billion INR | 15.56% |
| 2015 Q3 | 17.46 Billion INR | -7.04% |
| 2015 Q4 | 21.99 Billion INR | 25.94% |
| 2015 Q1 | 16.25 Billion INR | -7.3% |
| 2014 Q1 | 14.77 Billion INR | -8.86% |
| 2014 FY | 65.21 Billion INR | 10.09% |
| 2014 Q4 | 17.53 Billion INR | 3.65% |
| 2014 Q3 | 16.92 Billion INR | 1.23% |
| 2014 Q2 | 16.71 Billion INR | 13.11% |
| 2013 Q4 | 16.21 Billion INR | 1.27% |
| 2013 FY | 59.23 Billion INR | 19.21% |
| 2013 Q2 | 14.63 Billion INR | 18.19% |
| 2013 Q1 | 12.37 Billion INR | -7.31% |
| 2013 Q3 | 16.01 Billion INR | 9.45% |
| 2012 Q3 | 13.81 Billion INR | 10.04% |
| 2012 Q4 | 13.35 Billion INR | -3.31% |
| 2012 FY | 49.69 Billion INR | 23.59% |
| 2012 Q1 | 10.4 Billion INR | -2.39% |
| 2012 Q2 | 12.55 Billion INR | 20.64% |
| 2011 Q4 | 10.65 Billion INR | 3.37% |
| 2011 FY | 40.2 Billion INR | 36.34% |
| 2011 Q3 | 10.31 Billion INR | 0.0% |
| 2010 FY | 29.49 Billion INR | 17.93% |
| 2009 FY | 25 Billion INR | 18.18% |
| 2008 FY | 21.16 Billion INR | 5.32% |
| 2007 FY | 20.09 Billion INR | 60.54% |
| 2006 FY | 12.51 Billion INR | 65.2% |
| 2005 FY | 7.57 Billion INR | 23.78% |
| 2004 FY | 6.12 Billion INR | 60.79% |
| 2003 FY | 3.8 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ajanta Pharma Limited | 42.08 Billion INR | -180.682% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -2704.426% |
| Sigachi Industries Limited | 3.98 Billion INR | -2861.002% |
| Bal Pharma Limited | 3.39 Billion INR | -3382.434% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -822.25% |
| Medico Remedies Limited | 1.44 Billion INR | -8051.421% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -11222.276% |
| Venus Remedies Limited | 5.91 Billion INR | -1897.313% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -15537.104% |
| Alpa Laboratories Limited | 1.08 Billion INR | -10763.717% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -601.454% |
| Shilpa Medicare Limited | 11.51 Billion INR | -925.796% |
| Aarti Drugs Limited | 25.28 Billion INR | -367.184% |
| Lupin Limited | 200.1 Billion INR | 40.966% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 58.846% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 37.896% |
| Windlas Biotech Limited | 6.3 Billion INR | -1772.254% |
| Suven Life Sciences Limited | 116.92 Million INR | -100927.949% |
| Eris Lifesciences Limited | 20.09 Billion INR | -487.967% |
| Valiant Laboratories Limited | 1.82 Billion INR | -6388.673% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | -239.049% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -853.908% |
| Ipca Laboratories Limited | 76.22 Billion INR | -54.979% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -1433.681% |
| Achyut Healthcare Limited | 61.36 Million INR | -192392.904% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 75.642% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -2395.279% |
| RPG Life Sciences Limited | 5.82 Billion INR | -1929.567% |
| Mankind Pharma Limited | 103.34 Billion INR | -14.304% |
| Laurus Labs Limited | 50.01 Billion INR | -136.177% |
| Piramal Pharma Limited | 81.71 Billion INR | -44.571% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -4456.748% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | -11.387% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -93.274% |
| Unichem Laboratories Limited | 16.57 Billion INR | -612.742% |
| Sequent Scientific Limited | 13.69 Billion INR | -762.439% |
| Novartis India Limited | 3.35 Billion INR | -3425.561% |
| Wanbury Limited | 5.75 Billion INR | -1952.133% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -1023.608% |
| Wockhardt Limited | 27.89 Billion INR | -323.56% |
| Themis Medicare Limited | 3.81 Billion INR | -2994.371% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -5560.27% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -76.239% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -417.389% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 57.684% |
| Divi's Laboratories Limited | 78.45 Billion INR | -50.581% |
| NATCO Pharma Limited | 40.02 Billion INR | -195.18% |
| Gufic Biosciences Limited | 8.06 Billion INR | -1364.435% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -457.495% |
| Ind-Swift Limited | 5.02 Billion INR | -2251.014% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -926.102% |
| FDC Limited | 19.42 Billion INR | -508.0% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -23328.69% |
| Granules India Limited | 45.06 Billion INR | -162.142% |
| Medicamen Biotech Limited | 1.79 Billion INR | -6488.226% |
| Alkem Laboratories Limited | 126.67 Billion INR | 6.745% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -811.835% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -29406.703% |
| Brooks Laboratories Limited | 794.86 Million INR | -14761.84% |
| Megasoft Limited | 373.95 Million INR | -31489.791% |
| ZIM Laboratories Limited | 3.67 Billion INR | -3115.11% |
| Strides Pharma Science Limited | 40.51 Billion INR | -191.6% |
| Neuland Laboratories Limited | 15.58 Billion INR | -657.939% |
| Morepen Laboratories Limited | 17.01 Billion INR | -594.113% |
| Hikal Limited | 17.84 Billion INR | -561.946% |
| Indoco Remedies Limited | 17.89 Billion INR | -560.152% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -550.678% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -7552.333% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -3104.901% |
| Hester Biosciences Limited | 3.04 Billion INR | -3778.92% |